Endocanna Health Announces Involvement In Largest Ever Cannabinoid Hyperemesis Syndrome (CHS) Study
July 07, 2020 08:15 ET
|
Endocanna Health, Inc.
BURBANK, CA, July 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Endocanna Health, Inc. (“Endocanna” or the “Company”), a research and development biotechnology company specializing in...
Endocanna Health Announces New Immune Function Genetics Report
June 22, 2020 08:30 ET
|
Endocanna Health, Inc.
BURBANK, CA, June 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Endocanna Health, Inc. (“Endocanna” or the “Company”), a research and development biotechnology company specializing in...
Dr. Ethan Russo Joins Endocanna Health's Newly Created Science Board as Chairman
April 08, 2020 11:00 ET
|
Endocanna Health, Inc.
Burbank, California, April 08, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Endocanna Health, Inc. (“Endocanna” or the “Company”), a research and development biotechnology company specializing in...
Endocanna Health Launches 25 New Trait Reports and Personalized Cannabinoid Matching Product Marketplace
April 01, 2020 12:00 ET
|
Endocanna Health, Inc.
Burbank, California, April 01, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Endocanna Health, Inc. (“Endocanna” or the “Company”), a research and development biotechnology company specializing in...
Endocanna Health Creates Science Board to Further Cannabinoid and Genomics Research
March 26, 2020 09:00 ET
|
Endocanna Health, Inc.
Burbank, CA, March 26, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Endocanna Health, Inc. (“Endocanna” or “the Company”), a research and development biotechnology company specializing in...